ACRS FY 2025 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

FY 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$8M-58.2% YoY

Gross Profit

$6M73.3% margin

Operating Income

-$76M-975.9% margin

Net Income

-$65M-829.6% margin

EPS (Diluted)

$-0.53

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$47M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$160M

Total Liabilities

$57M

Stockholders' Equity

$103M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$19M	-58.2%
Gross Profit	$6M	$16M	-64.0%
Operating Income	-$76M	-$142M	+46.2%
Net Income	-$65M	-$132M	+50.8%